Table 1.

ZFP91 is an independent prognosis factor for OS for patients with HCC

Clinical character	OS (months)
	Univariate analysis		Multivariatie analysis
	HR (95% CI)	P value*	HR (95% CI)	P value*
Age (>50y vs. ≤ 50)	1.092 (0.620-1.924)	0.761	1.032 (0.548-1.945)	0.921
Gender (Female vs. Male)	1.715 (0.770-3.820)	0.187	2.523 (0.94606.730)	0.064
Cirrhosis (yes vs. no)	0.823 (0.369-1.837)	0.635	0.369 (0.129-1.055)	0.063
Histological Grade (G1-2,G2 vs. G2-3,G3)	0.957 (0.526-1.740)	0.886	0.617 (0.318-1.196)	0.153
TNM stage (I vs. II)	1.627 (0.926-2.858)	0.09	0.986 (0.325-2.987)	0.980
Tumor size (≤ 3 cm vs. > 3 cm)	2.273 (1.159-4.457)	0.017	3.690 (1.601-8.503)	0.002
Tumor number (≤ 3 n vs. > 3 n)	1.504 (0.767-2.947)	0.235	0.971 (0.471-2.005)	0.938
AFP (<400 μg/L vs. 400 μg/L)	1.790 (1.017-3.151)	0.044	0.569 (0.277-1.168)	0.124
Cirrhosis Nodule size (≤ 3 mm vs. > 3mm)	1.093 (0.622-1.920)	0.757	0.691 (0.356-1.341)	0.274
Clinical stage (I vs. II)	1.888 (1.069-3.337)	0.029	1.006 (0.336-3.016)	0.992
Recurrence (yes vs. no)	6.461 (2.884-14.473)	0.000	9.474 (3.680-24.392)	0.000
ZFP91	0.256 (0.127-0.515)	0.000	0.320 (0.149-0.689)	0.004

*Cox multivariate proportional hazard model.